Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-infected women on highly active antiretroviral therapy in rural uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 1, 2010, Pages 28-35

  Homsy, Jaco ^a   Moore, David ^b   Barasa, Alex ^c   Were, Willi ^c   Likicho, Celina ^c   Waiswa, Bernard ^c   Downing, Robert ^c   Malamba, Samuel ^a   Tappero, Jordan ^c   Mermin, Jonathan ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CDC Uganda   (Uganda)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; Breastfeeding; Highly active antiretroviral therapy; HIV; Infant mortality; Mother to child transmission; Uganda

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; BREAST FEEDING; BREAST FEEDING EDUCATION; CD4 LYMPHOCYTE COUNT; DELIVERY; DIARRHEA; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MATERNAL MORTALITY; NUTRITIONAL COUNSELING; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RURAL AREA; SINGLE DRUG DOSE; UGANDA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; VOMITING; WEANING;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT MORTALITY; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; MOTHERS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RURAL POPULATION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UGANDA; YOUNG ADULT;

EID: 74049098671     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181bdf65a     Document Type: Article

References (40)

1. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465
2. UNAIDS. 2008 Report on the Global AIDS Epidemic. WHO Library Cataloguing-in-Publication Data: UNAIDS/08.25E/JC1510E. WHO, Geneva, Switzerland
3. Ministry of Health Uganda and ORC Macro. Uganda HIV/AIDS Sero-Behavioral Survey 2004-2005. Kampala and Calverton: Uganda Ministry of Health and ORC Macro; March 2006.
4. Thomas T, Masaba R, Ndivo R, et al. Prevention of Mother-to-Child Transmission of HIV-1 among breastfeeding mothers using HAART: The Kisumu Breastfeeding Study, Kisumu, Kenya, 2003-2007. Presented at: 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2007; Boston, MA. Session 14, Abstract 45aLB.
5. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother to child transmission of HIV-1 through breastfeeding by treating mothers prophylactically with triple antiretroviral therapy in Dar es Salaam, Tanzania-the MITRA PLUS study. Presented at: 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia, July 22-25, 2007. Abstract TuAX101.
6. Towne-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med. 2007;4:1362-1373.
7. Ekouevi D, Coffie P, Benaud B, et al. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire. AIDS. 2008;22:1815-1820.
8. Taha T, Kumwenda J, Kafulafula G, et al. Maternal highly active anti-retroviral treatment (HAART): does it improve child survival? Abstract MOPEB083 presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
9. Chasela C, Hudgens M, Jamieson D, et al. Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study. Abstract WELBC103 presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
10. Shapiro R, Hughes M, Ogwu A, et al. A randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and the prevention of mother-to-child HIV transmission among breastfeeding women in Botswana (The Mma Bana Study). Abstract WELBB101 presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa
11. Kesho Bora Study Group. Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. Abstract LBPEC01 presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
12. Ministry of Health Uganda, AIDS Control Programme. National Guidelines for the Prevention of Mother to Child HIV Transmission. Revised ed. August, 2006.
13. Menzies N, Homsy J, Chang Pitter JY, et al. The cost-effectiveness of routine rapid HIV antibody testing before DNA-PCR testing for early infant HIV diagnosis in resource-limited settings. Pediatr Infect Dis J. 2009;28:819-825.
14. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
15. Rollins NC, Becquet R, Bland RM, et al. Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS. 2008;22:2349-2357.
16. Kuhn L, Aldrovandi GM, Sinkala M, et al. Zambia Exclusive Breastfeeding Study. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008;359:130-141.
17. Thior I, Lockman S, Smeaton LM, et al. Mashi Study Team. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296:794-805.
18. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J. 2004;23:536-543.
19. Kagaayi J, Gray RH, Brahmbhatt H, et al. Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda. PLoS One. 09 Dec 2008, doi:10.1371/journal.pone.0003877.
20. Kourtis A, Fitzgerald D, Hyde L, et al., and the BAN Study Team. Diarrhea in uninfected infants of HIV-infected mothers who stop breastfeeding at 6 months: The BAN Study Experience. Poster 772 presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 25-28, 2007; Los Angeles, CA.
21. Thomas T, Masaba R, van Eijk A, et al. Rates of diarrhea associated with early weaning among infants in Kisumu, Kenya. Poster 774 presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 25-28, 2007; Los Angeles, CA.
22. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality with Early Weaning in HIV-uninfected Children born to HIV-Infected Women in Malawi. J Acquir Immune Defic Syndr. 2010;53:6-13.
23. Onyango-Makumbi C, Bagenda D, Mwatha A, et al. Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda. J Acquir Immune Defic Syndr. 2010;53:20-27.
24. Creek T, Kim A, Lu L, et al. Hospitalization and Mortality Among Primarily Non-Breastfed Children During a Large Outbreak of Diarrhea and Malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr. 2010;53:14-19
25. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet. 2000;355:451-455.
26. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-unin-fected children: a prospective cohort study. Lancet. 2008;371:752-759.
27. Uganda Bureau of Statistics, Ministry of Health and Macro International Inc., USA Uganda Demographic and Health Survey 2006. Uganda Ministry of Health, August 2007, Kampala, Uganda.
28. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr. 2006;41:504-508.
29. Zaba B, Whitworth J, Marston M, et al. HIV and mortality of mothers and children: evidence from cohort studies in Uganda, Tanzania, and Malawi. Epidemiology. 2005;16:275-280.
30. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis. 2005;41:1654-1661.
31. WHO, UNICEF, UNAIDS & UNFPA. &UNFPA. HIVand Infant Feeding: New evidence and programmatic experience. Report of a Technical Consultation held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and their Infants HIV and Infant Feeding, Geneva, Switzerland, 25-27 October 2006. WHO Press 2007, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
32. Nduati R, Richardson BA, John G, et al. Effect of breastfeeding on mortality among HIV-1 infected women: a randomized trial. Lancet. 2001; 357:1651-1655.
33. Iliff PJ, Piwoz EG, Tavengwa NV, et al. ZVITAMBO study group. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005:19: 699-708.
34. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107-1116.
35. Horvath T, Madi BC, Iuppa IM, et al. Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev. 2009:CD006734.
36. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129.
37. Bedri A, Gudetta B, Isehak A, et al. Six Week Extended-Dose Nevirapine (SWEN) Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet. 2008;372:300-313.
38. Taha TE, Kumwenda NI, Hoover DR, et al. The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa. Bull World Health Organ. 2006;84:546-554.
39. Becquet R, Bequet L, Ekouevi DK, et al. ANRS 1201/1202 Ditrame Plus Study Group. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Cǒte d'Ivoire. PLoS Med. 2007;4:e17.
40. Mofenson L. Antiretroviral prophylaxis to reduce breast milk transmission of HIV type 1: new data but still questions. JAIDS. 2008;48: 237-240.